<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Earlier studies have reported the production of <z:chebi fb="11" ids="18295">histamine</z:chebi> in <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>The effect of <z:chebi fb="11" ids="18295">histamine</z:chebi> is largely determined locally by the <z:chebi fb="11" ids="18295">histamine</z:chebi> receptor expression pattern </plain></SENT>
<SENT sid="2" pm="."><plain>Recent evidence suggests that the expression level of <z:chebi fb="11" ids="18295">histamine</z:chebi> receptor H4 (HRH4) is abnormal in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> tissues </plain></SENT>
<SENT sid="3" pm="."><plain>However, the role of HRH4 in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> progression and its clinical relevance is not well understood </plain></SENT>
<SENT sid="4" pm="."><plain>The aim of this study is to evaluate the clinical and molecular phenotypes of <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumors</z:e> with abnormal HRH4 expression </plain></SENT>
<SENT sid="5" pm="."><plain>METHODS: Immunoblotting, real-time PCR, immunofluorescence and immunohistochemistry assays were adopted to examine HRH4 expression in case-matched <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> samples (n = 107) and adjacent <z:mpath ids='MPATH_458'>normal</z:mpath> tissues (ANTs) </plain></SENT>
<SENT sid="6" pm="."><plain>To assess the functions of HRH4 in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells, we established stable HRH4-transfected colorectal cells and examined cell proliferation, colony formation, cell cycle and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in these cells </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: The protein levels of HRH4 were reduced in most of the human <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> samples regardless of grade or Dukes classification </plain></SENT>
<SENT sid="8" pm="."><plain><z:chebi fb="2" ids="33699">mRNA</z:chebi> levels of HRH4 were also reduced in both early-stage and advanced <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> samples </plain></SENT>
<SENT sid="9" pm="."><plain>In vitro studies showed that HRH4 over-expression caused <z:mpath ids='MPATH_73'>growth arrest</z:mpath> and induced expression of cell cycle proteins in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells upon exposure to <z:chebi fb="11" ids="18295">histamine</z:chebi> through a cAMP -dependent pathway </plain></SENT>
<SENT sid="10" pm="."><plain>Furthermore, HRH4 stimulation promoted the 5-Fu-induced cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in HRH4-positive colorectal cells </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION: The results from the current study supported previous findings of HRH4 abnormalities in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>Expression levels of HRH4 could influence the <z:chebi fb="11" ids="18295">histamine</z:chebi>-mediated growth regulation in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells </plain></SENT>
<SENT sid="13" pm="."><plain>These findings suggested a potential role of abnormal HRH4 expression in the progression of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> and provided some new clues for the application of HRH4-specific <z:chebi fb="4" ids="48705">agonist</z:chebi> or <z:chebi fb="68" ids="48706">antagonist</z:chebi> in the molecular therapy of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> </plain></SENT>
</text></document>